677 related articles for article (PubMed ID: 1373963)
21. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Widlund KF; Gottvall T
Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
[TBL] [Abstract][Full Text] [Related]
22. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
Wald NJ; Watt HC; Hackshaw AK
N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
[TBL] [Abstract][Full Text] [Related]
23. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
[TBL] [Abstract][Full Text] [Related]
24. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
Morris JK; Bestwick J; Wald NJ
J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
[TBL] [Abstract][Full Text] [Related]
25. Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
Milunsky A; Sapirstein VS
Obstet Gynecol; 1982 Jan; 59(1):1-5. PubMed ID: 6176922
[TBL] [Abstract][Full Text] [Related]
26. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
27. Maternal serum screening for birth defects: results of a Connecticut regional program.
Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
[TBL] [Abstract][Full Text] [Related]
28. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
29. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
[TBL] [Abstract][Full Text] [Related]
30. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G
Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458
[TBL] [Abstract][Full Text] [Related]
31. Maternal serum screening in Ontario using the triple marker test.
Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
[TBL] [Abstract][Full Text] [Related]
32. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
[TBL] [Abstract][Full Text] [Related]
33. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
Crossley JA; Aitken DA; Berry E; Connor JM
J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
[TBL] [Abstract][Full Text] [Related]
34. Antenatal screening for Down's syndrome.
Wald NJ; Kennard A; Hackshaw A; McGuire A
J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
[TBL] [Abstract][Full Text] [Related]
35. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
[TBL] [Abstract][Full Text] [Related]
36. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L
BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768
[TBL] [Abstract][Full Text] [Related]
37. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
38. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
Wald NJ; George L; Smith D; Densem JW; Petterson K
Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
[TBL] [Abstract][Full Text] [Related]
39. Antenatal diagnosis of neural tube defects in Canada: extension of a collaborative study.
Simpson NE; Dallaire L; Miller JR; Siminovitch L; Miller J; Hamerton JL
Can Med Assoc J; 1979 Mar; 120(6):653-7. PubMed ID: 86382
[TBL] [Abstract][Full Text] [Related]
40. Prenatal screening for Down's syndrome.
Gocze PM; Arany A; Freeman DA
N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
